• How we work
    • Software
    • Smarts
    • Service
  • Solutions
    • Mapping
    • Measuring
    • Monitoring
  • Insights
    • Latest thinking
    • Resources
  • About
    • Who we are
    • Team
    • Careers
    • Contact us
  • Client login
Stakeholder Mapping in Pharma M&A Communications: Pfizer’s Acquisition of Seagen

Stakeholder Mapping in Pharma M&A Communications: Pfizer’s Acquisition of Seagen

by Commetric | Aug 17, 2023 | Blog

Download Commetric’s comprehensive media evaluation report on mergers and acquisitions (M&A) in the healthcare sector In today’s complex healthcare and media landscape, stakeholder mapping has never been more vital for pharma M&A communications. For...
8 Strategic Moves by Pfizer: Is This the Blueprint for Pharma M&A Communications?

8 Strategic Moves by Pfizer: Is This the Blueprint for Pharma M&A Communications?

by Commetric | Aug 17, 2023 | Blog

Pfizer has long been at the forefront of innovation and growth in the healthcare industry. In its recent M&A activities, the company has provided a roadmap for how to leverage corporate communications to create value and reinforce its brand positioning....
ASCO 2023 Unleashed New Era of Patient Power and Cutting-Edge Therapies. Here Are the PR Takeaways

ASCO 2023 Unleashed New Era of Patient Power and Cutting-Edge Therapies. Here Are the PR Takeaways

by Commetric | Jun 10, 2023 | Blog

The 2023 ASCO Annual Meeting presented a multitude of clinical research data on cancer care practices, with a major focus on advancements in breast cancer treatment. Our media analysis found that Novartis’ Kisqali was widely praised for its promise of boosting...
ESMO 2022: How Did An Oncology Congress Manage to Create Media Buzz?

ESMO 2022: How Did An Oncology Congress Manage to Create Media Buzz?

by Commetric | Sep 26, 2022 | Blog

This year’s European Society for Medical Oncology (ESMO) Congress was closely followed by specialised pharma outlets and managed to generate interest in daily media as well. Our media analysis found that a new study linking pollution...
Why Did a Study on Depression Cause a Media Frenzy? Insights from the Recent Debate Around Antidepressants

Why Did a Study on Depression Cause a Media Frenzy? Insights from the Recent Debate Around Antidepressants

by Commetric | Aug 5, 2022 | Blog

A new UCL study made headlines for “debunking” the serotonin imbalance theory of depression and caused a Twitter storm. Our media analysis found that the reaction from many researchers suggested that the serotonin imbalance theory has not been treated seriously...
Prev123Next

Recent Posts

  • Commetric triumphs at the DataComms Awards 2025
  • When is a Newsletter NOT a Newsletter?
  • Commetric shortlisted for two DataComms Awards 2025
  • Commetric Announces Leadership Changes: Solheim as Non-Executive Chairman, Minkovski as Interim CEO
  • From product to process: how the FMCG sustainability communications evolved

Tags

AI AMEC Brand management Climate Change Consumer Trends Corporate Communication Corporate Reputation COVID-19 Business Impact Tracker Crisis Communications Crisis Management Digital Marketing Diversity and Inclusion ESG Fashion Financial Services Food and Drink Health & Wellness Health and Wellness Immunotherapy Influencer Marketing Influencer Network Analysis Media Analytics Media Intelligence Media Monitoring Net Zero Oncology Pharma PR PR Analytics Precision Medicine PR Measurement PR Strategy Public Affairs Public Relations Regeneration Reputation Management Social Media Social Media Analytics Social Media Marketing Sports Strategic Communications Sustainability Tech Technology Twitter

How we work

Software

Smarts

Service

Solutions

Mapping

Measuring

Monitoring

Information

Insights

Resources

Who we are

Team

Careers

Privacy Policy

GDPR Policy

Contact

E-mail:
info@commetric.com

Phone:
+44 (0) 845 287 3003

  • Follow
  • Follow
Copyright ©2025 Commetric